Bi-Monthly Blood Cancer Financial Q&A: Expert Answers to Your Treatment Costs and Support Questions image

Bi-Monthly Blood Cancer Financial Q&A: Expert Answers to Your Treatment Costs and Support Questions

Feb 04, 2025
01:00PM - 02:00PM EST
Online Event
Overview

Join us for our bi-monthly financial Q&A featuring, our amazing in-house financial expert, Diahanna Vallentine! This engaging session is your opportunity to get answers to your pressing questions about blood cancer treatment costs, insurance coverage, and financial resources available to you. Whether you have specific concerns or just want to learn more about managing your finances during treatment, Diahanna is here to provide valuable insights and guidance. Don't miss this chance to empower yourself with the information you need to navigate the financial aspects of your care!

Please submit your questions in advance here.

Highlights
Agenda
1:00 PM
Introductions
Cynthia Cahoon, RN

Cynthia introduces the agenda of the event and featured speaker Diahanna Vallentine.  

1:05 PM
Questions and Answers
Diahanna Vallentine

Diahanna answers your financial questions!

Speakers & Moderators
Healthtree contact Cynthia Cahoon, RN

Cynthia Cahoon, RN

Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Healthtree contact Diahanna Vallentine

Diahanna Vallentine

Diahanna is the Financial Program Manager for the HealthTree Foundation. She specializes in providing financial help, resources and education for multiple myeloma patients. As a professional financial consultant and former caregiver of her husband who was diagnosed with multiple myeloma, Diahanna perfectly understands the financial issues facing myeloma patients.